Skip to main content
. 2022 Nov 25;2(1):100516. doi: 10.1016/j.jscai.2022.100516

Figure 4.

Figure 4

Forest plot of the rate of major bleeding, vascular complications, stroke, and mean mitral valve gradient at follow-up in patients with failed bioprostheses who underwent mitral valve-in-valve (MViV) versus those in patients who underwent redo surgical mitral valve replacement (SMVR). OR, odds ratio.